Safety and efficacy of pharmacological approaches available for multisystem inflammatory syndrome in children (MIS-C): a systematic review
Y Velusamy, G Vivekanandan, MH Romli… - The Turkish Journal …, 2023 - turkjpediatr.org
Background. To describe the existing pharmacological managements for Multisystem
Inflammatory Syndrome in Children (MIS-C) in a systematic way, to identify the available …
Inflammatory Syndrome in Children (MIS-C) in a systematic way, to identify the available …
Safety and efficacy of pharmacological approaches available for multisystem inflammatory syndrome in children (MIS-C): a systematic review
Y Velusamy, G Vivekanandan… - The Turkish journal …, 2023 - pubmed.ncbi.nlm.nih.gov
Background To describe the existing pharmacological managements for Multisystem
Inflammatory Syndrome in Children (MIS-C) in a systematic way, to identify the available …
Inflammatory Syndrome in Children (MIS-C) in a systematic way, to identify the available …
Safety and efficacy of pharmacological approaches available for multisystem inflammatory syndrome in children (MIS-C): a systematic review.
Y Velusamy, G Vivekanandan… - Turkish Journal of …, 2023 - search.ebscohost.com
Background. To describe the existing pharmacological managements for Multisystem
Inflammatory Syndrome in Children (MIS-C) in a systematic way, to identify the available …
Inflammatory Syndrome in Children (MIS-C) in a systematic way, to identify the available …
Safety and efficacy of pharmacological approaches available for multisystem inflammatory syndrome in children (MIS-C): a systematic review
Y Velusamy, G Vivekanandan… - The Turkish Journal …, 2023 - search.proquest.com
Abstract World Health Organization (WHO) criteria for MIS-C comprises, patients are less
than 19 years old with fever (more than three days). inflammatory laboratory evidence …
than 19 years old with fever (more than three days). inflammatory laboratory evidence …
[PDF][PDF] Safety and efficacy of pharmacological approaches available for multisystem inflammatory syndrome in children (MIS-C): a systematic review
Y Velusamy, G Vivekanandan, MH Romli… - The Turkish Journal …, 2023 - researchgate.net
Background. To describe the existing pharmacological managements for Multisystem
Inflammatory Syndrome in Children (MIS-C) in a systematic way, to identify the available …
Inflammatory Syndrome in Children (MIS-C) in a systematic way, to identify the available …
Safety and efficacy of pharmacological approaches available for multisystem inflammatory syndrome in children (MIS-C): a systematic review.
Y Velusamy, G Vivekanandan, MH Romli… - The Turkish Journal …, 2023 - europepmc.org
Background To describe the existing pharmacological managements for Multisystem
Inflammatory Syndrome in Children (MIS-C) in a systematic way, to identify the available …
Inflammatory Syndrome in Children (MIS-C) in a systematic way, to identify the available …